2. Academic Validation
  3. Current pharmacologic testing for Horner syndrome

Current pharmacologic testing for Horner syndrome

  • Curr Neurol Neurosci Rep. 2009 Sep;9(5):384-9. doi: 10.1007/s11910-009-0056-z.
Mansoor Mughal 1,  Reid Longmuir
Affiliations

Affiliation

  • 1 The University of Iowa Hospitals and Clinics, Department of Ophthalmology and Visual Sciences, IA 52242, USA.
PMID: 19664368 DOI: 10.1007/s11910-009-0056-z
Abstract

First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculosympathetic pathway. Its presence can be confirmed with pharmacologic testing, traditionally including cocaine testing with hydroxyamphetamine localization. More recently, apraclonidine testing has become a viable alternative in some practices. Concern has been raised regarding the possibility of false-negative results with apraclonidine testing as well as the safety of its use in young children.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z